Dosage regimens of anti-LAG-3 antibodies and uses thereof
- 专利权人:
- Novartis AG
- 发明人:
- STEIN, Andrew Marc,VOGL, Florian Dominik,SELLAMI, Dalila
- 申请号：
- AU2018302283
- 公开号：
- AU2018302283A1
- 申请日:
- 2018.07.20
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要：
- Dosage regimens for antibody molecules that specifically bind to LAG-3 are disclosed. The antibody molecules can be used to treat or prevent cancerous or infectious conditions and disorders.
- 来源网站：
- 中国工程科技知识中心
